After the ‘Jackpot’ of Hanmi, other companies’ pipelines attract interests
As Hanmi Pharm, which put all its effort in R&D, signed 6 gigantic license agreements with multinational pharmaceutical companies only this year, other domestic pharmaceutical companies’ pipelines have started to attract interests of others.
According to the industry concerned and the securities...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
